LGT Capital Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-544,700
Closed -$51.4M 75
2019
Q1
$51.4M Sell
544,700
-120,766
-18% -$10.6M 3.79% 4
2018
Q4
$42.6M Buy
665,466
+131,880
+25% +$9.74M 3.53% 5
2018
Q3
$47.8M Sell
533,586
-29,030
-5% -$2.57M 3.7% 6
2018
Q2
$44.7M Buy
562,616
+117,031
+26% +$9.72M 3.48% 7
2018
Q1
$39.8M Buy
445,585
+90,735
+26% +$8.71M 3.4% 6
2017
Q4
$37M Buy
354,850
+98,665
+39% +$11.1M 3.46% 6
2017
Q3
$37.4M Sell
256,185
-1,805
-0.7% -$246K 3.76% 2
2017
Q2
$33.5M Buy
257,990
+44,435
+21% +$5.44M 3.36% 4
2017
Q1
$26.6M Buy
213,555
+121,555
+132% +$14.5M 3.02% 5
2016
Q4
$10.6M Buy
92,000
+25,660
+39% +$2.86M 1.45% 32
2016
Q3
$6.93M Buy
+66,340
New +$7.18M 0.97% 46

Other funds holding CELG

LGT Capital Partners's CELG Position: Q2 2019 in Review

LGT Capital Partners sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 544,700 shares — an estimated $51.4M sold.

LGT Capital Partners first reported a position in CELG in Q3 2016 and held it in 11 quarters. The position peaked at $51.4M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • LGT Capital Partners reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • LGT Capital Partners sold 544,700 Celgene Corp shares in Q2 2019, an estimated $51.4M.
  • LGT Capital Partners first reported a position in Celgene Corp in Q3 2016 and held it in 11 quarters.
  • LGT Capital Partners's Celgene Corp position peaked at $51.4M in Q1 2019.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on LGT Capital Partners's 13F filing for Q2 2019, filed 10 Jul 2019.